← Back to Search

Behavioural Intervention

Handgrip Exercise Group for Deep Vein Thrombosis

N/A
Recruiting
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from picc placement to picc removal, up to 4 weeks
Awards & highlights

Study Summary

"This trial aims to study the effectiveness of hand grip exercises in reducing the risk of developing blood clots in adult patients with a peripherally-inserted central catheter (PICC) placed. Approximately

Who is the study for?
This trial is for adult patients who have a PICC line in place and are currently hospitalized. The goal is to see if handgrip exercises can prevent deep vein thrombosis (DVT), which is a type of blood clot that can occur with PICC lines.Check my eligibility
What is being tested?
The study tests whether doing handgrip exercises can reduce the risk of developing DVT in patients with peripherally-inserted central catheters. It's the first study of its kind in the U.S., aiming to find an innovative prevention method.See study design
What are the potential side effects?
Since this trial involves non-invasive handgrip exercises, side effects are expected to be minimal. However, participants may experience mild discomfort or fatigue in their hands from the exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from picc placement to picc removal, up to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and from picc placement to picc removal, up to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Deep vein thrombosis

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Handgrip Exercise GroupExperimental Treatment1 Intervention
Participants will be instructed to firmly grip and squeeze the ball for 10 seconds, relax for 10 seconds and repeat for 10 minutes. They will be instructed to do this 3 times per day.
Group II: Standard Care GroupActive Control1 Intervention
Participants will receive standard care that includes no instruction about conducting hand grip exercises.

Find a Location

Who is running the clinical trial?

TriHealth Inc.Lead Sponsor
97 Previous Clinical Trials
51,088 Total Patients Enrolled
1 Trials studying Deep Vein Thrombosis
100 Patients Enrolled for Deep Vein Thrombosis
Rachel Baker, PhD, RNStudy ChairTriHealth Nurse Researcher

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current clinical trial open for new participant enrollment?

"According to the details on clinicaltrials.gov, this investigation is currently seeking volunteers. Initially shared on October 6th, 2023, it was last revised on April 15th, 2024."

Answered by AI

How large is the patient cohort involved in this ongoing medical study?

"Yes, the information available on clinicaltrials.gov affirms that this medical research study is presently enrolling individuals. The trial was originally posted on October 6th, 2023, and underwent its most recent revision on April 15th, 2024. Recruitment aims to encompass a cohort of 2500 patients from two designated locations."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluating the Use of Grip Exercises to Decrease Deep Vein Thrombosis in Adult Patients With PICC Lines
2023. "Evaluating the Use of Grip Exercises to Decrease Deep Vein Thrombosis in Adult Patients With PICC Lines". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06370702.
All > Cincinnati
~1667 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top